Literature DB >> 11959876

Overview of cancer in Malaysia.

Gerard Chin Chye Lim1.   

Abstract

The problem of cancer in Malaysia is a growing one. It is now the fourth leading cause of death among medically certified deaths. Cancer of the lung is the most common killer among malignancies. It is estimated that the annual incidence of cancer is 30 000. The majority of patients are found at a late stage of the disease. The National Cancer Control Program aims to reduce the incidence and mortality of cancer and to improve the quality of life of cancer patients. Policies encompass prevention, early diagnosis, treatment, palliative care and rehabilitation. The program for prevention includes an anti-smoking campaign and immunization of babies against hepatitis B. Papanicolaou's smear and breast self-examination are among efforts for the early detection of cancer. Public education and the promotion of healthy lifestyles have been actively carried out. Facilities for treatment and palliative care are being developed further. Networks between the public and private sectors and non-governmental organizations have been on-going. Apart from the establishment and upgrading of treatment facilities, the need for training of skilled staff in the treatment of cancer is highlighted.

Entities:  

Mesh:

Year:  2002        PMID: 11959876

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  18 in total

1.  The Socio-Demographic and Clinical Factors Associated with Quality of Life among Patients with Haematological Cancer in a Large Government Hospital in Malaysia.

Authors:  Das Priscilla; Awang Hamidin; Md Zain Azhar; Kon Noorjan; Md Said Salmiah; Khalid Bahariah
Journal:  Malays J Med Sci       Date:  2011-07

2.  Profile of men's health in Malaysia: problems and challenges.

Authors:  Seng Fah Tong; Wah Yun Low; Chirk Jenn Ng
Journal:  Asian J Androl       Date:  2011-02-28       Impact factor: 3.285

3.  Induction of selective cytotoxicity and apoptosis in human T4-lymphoblastoid cell line (CEMss) by boesenbergin a isolated from boesenbergia rotunda rhizomes involves mitochondrial pathway, activation of caspase 3 and G2/M phase cell cycle arrest.

Authors:  Kuan-Beng Ng; Ahmad Bustamam; Mohd Aspollah Sukari; Siddig Ibrahim Abdelwahab; Syam Mohan; Michael James Christopher Buckle; Behnam Kamalidehghan; Nabilah Muhammad Nadzri; Theebaa Anasamy; A Hamid A Hadi; Heshu Sulaiman Rahman
Journal:  BMC Complement Altern Med       Date:  2013-02-22       Impact factor: 3.659

4.  Clinical oncology in Malaysia: 1914 to present.

Authors:  Gcc Lim
Journal:  Biomed Imaging Interv J       Date:  2006-01-01

5.  Expanding the role of the oncology nurse.

Authors:  A Quinn
Journal:  Biomed Imaging Interv J       Date:  2008-07-01

6.  A qualitative exploration of Malaysian cancer patients' perspectives on cancer and its treatment.

Authors:  Maryam Farooqui; Mohamed A Hassali; Aishah K Shatar; Asrul A Shafie; Tan B Seang; Muhammad A Farooqui
Journal:  BMC Public Health       Date:  2011-07-01       Impact factor: 3.295

7.  Honey and cancer: sustainable inverse relationship particularly for developing nations-a review.

Authors:  Nor Hayati Othman
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-17       Impact factor: 2.629

Review 8.  Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials.

Authors:  Heshu Sulaiman Rahman; Abdullah Rasedee; Swee Keong Yeap; Hemn Hassan Othman; Max Stanley Chartrand; Farideh Namvar; Ahmad Bustamam Abdul; Chee Wun How
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

9.  Calls to Action (Mobilizing Information) on Cancer in Online News: Content Analysis.

Authors:  Thomas Hongjie Zhang; Jen Sern Tham
Journal:  J Med Internet Res       Date:  2021-06-21       Impact factor: 5.428

10.  In Silico Screening of Mutated K-Ras Inhibitors from Malaysian Typhonium flagelliforme for Non-Small Cell Lung Cancer.

Authors:  Ayesha Fatima; H F Yee
Journal:  Adv Bioinformatics       Date:  2014-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.